共 277 条
[1]
Niraula S(2011)Broadening horizons in medical management of prostate cancer Acta Oncol 50 141-147
[2]
Tannock IF(2014)Enzalutamide in metastatic prostate cancer before chemotherapy N Engl J Med 371 424-433
[3]
Beer TM(2011)Abiraterone and increased survival in metastatic prostate cancer N Engl J Med 364 1995-2005
[4]
Armstrong AJ(2013)Abiraterone in metastatic prostate cancer without previous chemotherapy N Engl J Med 368 138-148
[5]
Rathkopf DE(2012)Increased survival with enzalutamide in prostate cancer after chemotherapy N Engl J Med 367 1187-1197
[6]
Loriot Y(2007)Androgen signaling and its interactions with other signaling pathways in prostate cancer BioEssays 29 1227-1238
[7]
Sternberg CN(2014)AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer N Engl J Med 371 1028-1038
[8]
Higano CS(2017)Clinical significance of androgen receptor splice variant-7 mRNA detection in circulating tumor cells of men with metastatic castration-resistant prostate cancer treated with first- and second-line abiraterone and enzalutamide J Clin Oncol 35 2149-2156
[9]
Iversen P(2011)New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway Clin Cancer Res 17 1649-1657
[10]
Bhattacharya S(2014)Emerging mechanisms of enzalutamide resistance in prostate cancer Nat Rev Urol 11 712-716